HPV L1 capsid protein detection and progression of anal squamous neoplasia

American Journal of Clinical Pathology

Volumn 135, Issue 3, 2011, Pages 436-441

  Hernandez, Jonathan ^a   Elahi, Abul ^a   Siegel, Erin ^a   Coppola, Domenico ^a   Riggs, Bridgett ^a   Shibata, David ^a,b  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b Division of Gastrointestinal Tumors   (United States)

Author keywords

Anal neoplasms; HPV L1 capsid protein; Human papillomavirus; Squamous neoplasia

Indexed keywords

CAPSID PROTEIN L1; CAPSID PROTEIN; HPV L1 PROTEIN, HUMAN PAPILLOMAVIRUS; ONCOPROTEIN; TUMOR MARKER; VIRUS DNA;

ADULT; AGED; ANUS CARCINOMA; ARTICLE; CANCER GROWTH; CARCINOGENESIS; CLINICAL ARTICLE; FEMALE; GENOTYPE; HUMAN; HUMAN TISSUE; IMMUNOPATHOLOGY; MALE; NONHUMAN; PAPILLOMAVIRUS INFECTION; PRIORITY JOURNAL; PROGNOSIS; SQUAMOUS CELL CARCINOMA; VIRUS CAPSID; WART VIRUS; ANAL CANAL; ANUS TUMOR; CARCINOMA IN SITU; CELL NUCLEUS; DISEASE COURSE; HUMAN PAPILLOMAVIRUS TYPE 16; IMMUNOLOGY; INTESTINE MUCOSA; ISOLATION AND PURIFICATION; METABOLISM; MIDDLE AGED; PATHOLOGY; TUMOR RECURRENCE; VIROLOGY;

ADULT; AGED; AGED, 80 AND OVER; ANAL CANAL; ANUS NEOPLASMS; CAPSID PROTEINS; CARCINOMA IN SITU; CARCINOMA, SQUAMOUS CELL; CELL NUCLEUS; DISEASE PROGRESSION; DNA, VIRAL; FEMALE; HUMAN PAPILLOMAVIRUS 16; HUMANS; INTESTINAL MUCOSA; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; ONCOGENE PROTEINS, VIRAL; TUMOR MARKERS, BIOLOGICAL;

EID: 79954438425     PISSN: 00029173     EISSN: 19437722     Source Type: Journal    
DOI: 10.1309/AJCPR5VD6NSQRWBN     Document Type: Article

References (15)

1. Pereira R, Hitzeroth II, Rybicki EP. Insights into the role and function of L2, the minor capsid protein of papillomaviruses. Arch Virol. 2009;154:187-197.
2. Carter JJ, Madeleine MM, Shera K, et al. Human papillomavirus 16 and 18 L1 serology compared across anogenital cancer sites. Cancer Res. 2001;61:1934-1940. (Pubitemid 32692010)
3. Eng C. Anal cancer: current and future methodology. Cancer Invest. 2006;24:535-544. (Pubitemid 44576408)
4. Chan JK, Berek JS. Impact of the human papilloma vaccine on cervical cancer. J Clin Oncol. 2007;25:2975-2982. (Pubitemid 47123162)
5. Mahdavi A, Monk BJ. Vaccines against human papillomavirus and cervical cancer: promises and challenges. Oncologist. 2005;10:528-538. (Pubitemid 41266334)
6. Doorbar J. Molecular biology of human papillomavirus infection and cervical cancer. Clin Sci (Lond). 2006;110:525-541. (Pubitemid 43736116)
7. Rauber D, Mehlhorn G, Fasching PA, et al. Prognostic significance of the detection of human papilloma virus L1 protein in smears of mild to moderate cervical intraepithelial lesions. Eur J Obstet Gynecol Reprod Biol. 2008;140:258-262.
8. Griesser H, Sander H, Hilfrich R, et al. Correlation of immunochemical detection of HPV L1 capsid protein in Pap smears with regression of high-risk HPV positive mild/moderate dysplasia. Anal Quant Cytol Histol. 2004;26:241-245. (Pubitemid 39458640)
9. Yoshida T, Sano T, Kanuma T, et al. Immunochemical analysis of HPV L1 capsid protein and p16 protein in liquidbased cytology samples from uterine cervical lesions. Cancer. 2008;114:83-88. (Pubitemid 351640786)
10. Lee H, Lee KJ, Jung CK, et al. Expression of HPV L1 capsid protein in cervical specimens with HPV infection. Diagn Cytopathol. 2008;36:864-867.
11. Pineda CE, Welton ML. Controversies in the management of anal high-grade squamous intraepithelial lesions. Minerva Chir. 2008;63:389-399.
12. Palmer JG, Scholefield JH, Coates PJ, et al. Anal cancer and human papillomaviruses. Dis Colon Rectum. 1989;32:1016-1022. (Pubitemid 20020186)
13. Doorbar J. The papillomavirus life cycle. J Clin Virol. 2005;32(suppl 1):S7-S15. (Pubitemid 40332584)
14. Roden R, Wu TC. How will HPV vaccines affect cervical cancer? Nat Rev Cancer. 2006;6:753-763. (Pubitemid 44450464)
15. Feig BW, Berger DH, Fuhrman GM. The M. D. Anderson Surgical Oncology Handbook. Philadelphia, PA: Lippincott Williams & Wilkins; 2006.